[
  {
    "ts": null,
    "headline": "Crypto Industry Boosted Lobbying to Pass Coveted Stablecoin Bill",
    "summary": "(Bloomberg) -- Crypto companies and advocates of digital assets boosted their lobbying this year to ensure passage of landmark legislation, delivering the nascent industry its first major policy victory in Washington.Most Read from BloombergTrump Awards $1.26 Billion Contract to Build Biggest Immigrant Detention Center in USWhy the Federal Reserve’s Building Renovation Costs $2.5 BillionSalt Lake City Turns Winter Olympic Bid Into Statewide Bond BoomMilan Corruption Probe Casts Shadow Over Prope",
    "url": "https://finnhub.io/api/news?id=92a86b8118368f4a45435fbd48190cbe892591d7259c3bb60d35d406f77e33f5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753220807,
      "headline": "Crypto Industry Boosted Lobbying to Pass Coveted Stablecoin Bill",
      "id": 136038355,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "(Bloomberg) -- Crypto companies and advocates of digital assets boosted their lobbying this year to ensure passage of landmark legislation, delivering the nascent industry its first major policy victory in Washington.Most Read from BloombergTrump Awards $1.26 Billion Contract to Build Biggest Immigrant Detention Center in USWhy the Federal Reserve’s Building Renovation Costs $2.5 BillionSalt Lake City Turns Winter Olympic Bid Into Statewide Bond BoomMilan Corruption Probe Casts Shadow Over Prope",
      "url": "https://finnhub.io/api/news?id=92a86b8118368f4a45435fbd48190cbe892591d7259c3bb60d35d406f77e33f5"
    }
  },
  {
    "ts": null,
    "headline": "Pharma sector outlook as Trump's drug tariff deadline looms",
    "summary": "Pharmaceutical stocks are in focus as President Trump's drug tariff deadline looms. Yahoo Finance Senior Reporter Anjalee Khemlani joins Market Domination with Josh Lipton to discuss the impact that pharmaceutical tariffs could have on the sector, Astrazeneca’s (AZN) $50 billion commitment to US investments, and how the industry is navigating pressure from Washington and shifting global demand. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
    "url": "https://finnhub.io/api/news?id=70ca672e6fd4e363c7c1b4bb9ea9d687b46f09a425e0b23a0b520aada557cd1e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753214713,
      "headline": "Pharma sector outlook as Trump's drug tariff deadline looms",
      "id": 136038196,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pharmaceutical stocks are in focus as President Trump's drug tariff deadline looms. Yahoo Finance Senior Reporter Anjalee Khemlani joins Market Domination with Josh Lipton to discuss the impact that pharmaceutical tariffs could have on the sector, Astrazeneca’s (AZN) $50 billion commitment to US investments, and how the industry is navigating pressure from Washington and shifting global demand. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
      "url": "https://finnhub.io/api/news?id=70ca672e6fd4e363c7c1b4bb9ea9d687b46f09a425e0b23a0b520aada557cd1e"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. stock outperforms competitors on strong trading day",
    "summary": "Pfizer Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=531059412a64e35836f12dd1234274da5fffd60edbe202126f39877301150e20",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753202220,
      "headline": "Pfizer Inc. stock outperforms competitors on strong trading day",
      "id": 136043362,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=531059412a64e35836f12dd1234274da5fffd60edbe202126f39877301150e20"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. (NYSE:PFE) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed?",
    "summary": "Pfizer's (NYSE:PFE) stock up by 7.7% over the past three months. However, we decided to study the company's mixed-bag...",
    "url": "https://finnhub.io/api/news?id=e5b0aac4ca0c71183c04c692624bf2a682b1b0bbe1b07797a66284518a56a7e8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753185618,
      "headline": "Pfizer Inc. (NYSE:PFE) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed?",
      "id": 136031588,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer's (NYSE:PFE) stock up by 7.7% over the past three months. However, we decided to study the company's mixed-bag...",
      "url": "https://finnhub.io/api/news?id=e5b0aac4ca0c71183c04c692624bf2a682b1b0bbe1b07797a66284518a56a7e8"
    }
  }
]